AVASTIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Market Segmentation

•  Indication Insights (Revenue, USD Mn, 2021 - 2033)

  • Metastatic colorectal cancer
  • Non-squamous non-small cell lung cancer
  • Recurrent glioblastoma
  • Metastatic renal cell carcinoma
  • Persistent cervical cancer
  • Recurrent cervical cancer
  • Metastatic cervical cancer
  • Stage III or IV epithelial ovarian cancer
  • Stage III or IV fallopian tube cancer
  • Stage III or IV primary peritoneal cancer
  • Platinum-resistant recurrent epithelial ovarian cancer
  • Platinum-resistant recurrent fallopian tube cancer
  • Platinum-resistant recurrent primary peritoneal cancer
  • Platinum-sensitive recurrent epithelial ovarian cancer
  • Platinum-sensitive recurrent fallopian tube cancer
  • Platinum-sensitive recurrent primary peritoneal cancer
  • Hepatocellular carcinoma

•  Dose Strength Insights (Revenue, USD Mn, 2021 - 2033)

  • Vial (100 mg/4 mL)
  • Vial (400 mg/16 mL)

•  Sales Channel Insights (Revenue, USD Mn, 2021 - 2033)

  • Online
  • Offline

• Regional Insights (Revenue, USD Mn, 2021 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa